Hydromorphon ratiopharm Retardtabletten
Recall
|
Medicines
|
11/11/2024
The marketing authorisation holder informed its customers on November 11, 2024, that the information on the starting dose in the patient information leaflet for the mentioned strengths is incorrect. For this reason, the batches mentioned are being recalled.
| Name of the medicinal product | 1) Hydromorphon ratiopharm 8 mg Retardtabletten 2) Hydromorphon ratiopharm 16 mg Retardtabletten 3) Hydromorphon ratiopharm 24 mg Retardtabletten |
|---|---|
| Marketing authorisation number(s) | 1) 1-29273 2) 1-29274 3) 1-29275 |
| CIP code | 1) 3764844 2) 3764867 3) 3764896 |
| Marketing authorisation holder | Teva B.V. |
| Batch number(s) | 1) B239562, B336712 2) C336182 3) D337682 |
| Expiry date | 09/30/2027 |
| Classification of the recall | 2 |
| Depth of recall | Pharmacies |
| BASG reference number | INS-640.001-4982 |
Further inquiry note
Page last modified:
11/11/2024